Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Genotype and Environmental Risk Factors on Treatment Response to Intravitreal Lucentis (Ranibizumab) for Neovascular AMD

NCT00469352 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT00469352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00469352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Genotype and Environmental Risk Factors on Treatment Response to Intravitreal Lucentis (Ranibizumab) for Neovascular AMD
Lead sponsor
Oregon Health and Science University
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2007
Completion date
April 30, 2010
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular degeneration